Journal
PHARMACOGENOMICS
Volume 10, Issue 8, Pages 1277-1283Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.09.54
Keywords
angiogenesis; gene polymorphism; head and neck cancer; VEGF-A
Categories
Ask authors/readers for more resources
Aims: Elevated tumoral vascular endothelial growth factor A (VEGF-A) expression is linked to poor survival in head and neck cancer patients. The aim of the present study was to analyze the influence of VEGF-A gene polymorphisms on tumoral VEGF-A expression and to test their prognostic value in head and neck cancer patients. Materials & methods: VEGF-A polymorphisms at position -2578C > A, -1498T > C, -1154G > A, -634G > C and 936C > T were analyzed (PCR-RFLP) in tumoral DNA, along with tumoral VEGF-A expression (ELISA), in 49 Caucasian head and neck cancer patients. Results: A trend towards a difference in tumoral VEGF-A expression depending on 936C > T polymorphism was observed, with a median at 540 pg/mg prot in CT + TT patients (n = 5) versus 940 pg/mg prot in CC patients (n = 44) (p = 0.064). VEGF-A expression was not related to any other polymorphism. Unlike tumoral VEGF-A expression, the analyzed genotypes were not related to patient survival. Conclusion: As opposed to tumoral VEGF-A expression, VEGF-A gene polymorphisms are not of prognostic value in head and neck cancer patients. Further studies aimed at confirming the influence of VEGF-A 936C > T germinal polymorphism on tumoral VEGF-A expression are needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available